Research and experimental development on natural sciences and engineering
SERCA PHARMACEUTICALS AS
Revenue 2024
NOK 4.7m
Operating profit
NOK −1.5m
Equity
NOK 27.6m
Incorporated
2018
Share capital
NOK 896,000
Organisation
Established
2018-10-08
Industry code
72.100
Legal form
AS
Group structure
Eier · 40.4%
SARSIA SEED FOND II AS
Company
SERCA PHARMACEUTICALS AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Utvikle legemidler.
Business address
Gaustadalléen 21, 0349 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.